Kumar AJ - Search Results

1

Hematopoietic Stem-Cell Transplant Utilization in Relapsed/Refractory Hodgkin Lymphoma: A Population-Level Analysis of Statewide Claims Data.

Waheed A, Rodday AM, Kumar AJ, Miller KB, Parsons SK. Waheed A, et al. Among authors: kumar aj. JCO Clin Cancer Inform. 2022 May;6:e2100135. doi: 10.1200/CCI.21.00135. JCO Clin Cancer Inform. 2022. PMID: 35584337 Free article.

2

Disrupting autorepression circuitry generates "open-loop lethality" to yield escape-resistant antiviral agents.

Chaturvedi S, Pablo M, Wolf M, Rosas-Rivera D, Calia G, Kumar AJ, Vardi N, Du K, Glazier J, Ke R, Chan MF, Perelson AS, Weinberger LS. Chaturvedi S, et al. Among authors: kumar aj. Cell. 2022 Jun 9;185(12):2086-2102.e22. doi: 10.1016/j.cell.2022.04.022. Epub 2022 May 12. Cell. 2022. PMID: 35561685 Free PMC article.

3

Battlefield Acupuncture Use for Perioperative Anesthesia in Veterans Affairs Surgical Patients: A Single-Center Randomized Controlled Trial.

Baldawi M, McKelvey G, Patel VR, Krish B, Kumar AJ, Patel P. Baldawi M, et al. Among authors: kumar aj. J Integr Complement Med. 2022 Aug;28(8):683-688. doi: 10.1089/jicm.2021.0429. Epub 2022 May 6. J Integr Complement Med. 2022. PMID: 35527689 Clinical Trial.

4

Indigenous bacterial consortium-mediated cypermethrin degradation in the presence of organic amendments and Zea mays plants.

Bhatt P, Rene ER, Huang Y, Wu X, Zhou Z, Li J, Kumar AJ, Sharma A, Chen S. Bhatt P, et al. Among authors: kumar aj. Environ Res. 2022 Sep;212(Pt A):113137. doi: 10.1016/j.envres.2022.113137. Epub 2022 Mar 29. Environ Res. 2022. PMID: 35358545

5

Biotechnological tools to elucidate the mechanism of pesticide degradation in the environment.

Gangola S, Bhatt P, Kumar AJ, Bhandari G, Joshi S, Punetha A, Bhatt K, Rene ER. Gangola S, et al. Among authors: kumar aj. Chemosphere. 2022 Jun;296:133916. doi: 10.1016/j.chemosphere.2022.133916. Epub 2022 Feb 8. Chemosphere. 2022. PMID: 35149016 Review.

6

Treatment patterns for relapsed and refractory Hodgkin lymphoma in a community oncology setting.

Kumar AJ, Chao CR, Rodday AM, Chang H, Xu L, Evens AM, Parsons SK. Kumar AJ, et al. Leuk Lymphoma. 2022 May;63(5):1119-1126. doi: 10.1080/10428194.2021.2012660. Epub 2021 Dec 10. Leuk Lymphoma. 2022. PMID: 34886751

7

Laser-patterned paper-based flow-through filters and lateral flow immunoassays to enable the detection of C-reactive protein.

Galanis PP, Katis IN, He PJW, Iles AH, Kumar AJU, Eason RW, Sones CL. Galanis PP, et al. Among authors: kumar aju. Talanta. 2022 Feb 1;238(Pt 2):123056. doi: 10.1016/j.talanta.2021.123056. Epub 2021 Nov 9. Talanta. 2022. PMID: 34801912

8

Association of Treatment Intensity With Survival in Older Patients With Hodgkin Lymphoma.

Rodday AM, Hahn T, Kumar AJ, Lindenauer PK, Friedberg JW, Evens AM, Parsons SK. Rodday AM, et al. Among authors: kumar aj. JAMA Netw Open. 2021 Oct 1;4(10):e2128373. doi: 10.1001/jamanetworkopen.2021.28373. JAMA Netw Open. 2021. PMID: 34673965 Free PMC article.

9

Cancer-related impairments and functional limitations among long-term cancer survivors: Gaps and opportunities for clinical practice.

Nekhlyudov L, Campbell GB, Schmitz KH, Brooks GA, Kumar AJ, Ganz PA, Von Ah D. Nekhlyudov L, et al. Among authors: kumar aj. Cancer. 2022 Jan 15;128(2):222-229. doi: 10.1002/cncr.33913. Epub 2021 Sep 16. Cancer. 2022. PMID: 34529268 Free PMC article.

10

Hodgkin lymphoma survivor perspectives on their engagement in treatment decision-making and discussion of late effects.

Murphy-Banks R, Kumar AJ, Lin M, Savidge N, Livne E, Parsons SK. Murphy-Banks R, et al. Among authors: kumar aj. Support Care Cancer. 2022 Feb;30(2):1399-1405. doi: 10.1007/s00520-021-06538-6. Epub 2021 Sep 15. Support Care Cancer. 2022. PMID: 34524526

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results